SCHEMBL7781960

SCHEMBL7781960

CCCCCCCCCCCCCCCCOC(=O)C(N)CCC(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 3/20 0.60
S1PR1 P21453 1/20 0.53
S1PR3 Q99500 1/20 0.53
PLA2G2C Q5R387 1/20 0.48
GPR84 Q9NQS5 7/20 0.47
PPARG P37231 7/20 0.47
PPARD Q03181 7/20 0.47
PPARA Q07869 7/20 0.47
HDAC11 Q96DB2 5/20 0.47
TSHR P16473 4/20 0.47
PTPN1 P18031 3/20 0.47
ALDH1A1 P00352 2/20 0.47
TLR2 O60603 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
FABP4 P15090 2/20 0.47
SLC22A6 Q4U2R8 1/20 0.47
SLC22A8 Q8TCC7 1/20 0.47
MEN1 O00255 1/20 0.47
ESR1 P03372 1/20 0.47
ALOX15 P16050 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7198231 1.00 NOD1 (0.60) NOD1S1PR1S1PR3PLA2G2CGPR84
SCHEMBL1697604 1.00 NOD1 (0.60) NOD1S1PR1S1PR3PLA2G2CGPR84
SCHEMBL9005497 1.00 NOD1 (0.60) NOD1S1PR1S1PR3PLA2G2CGPR84
SCHEMBL7782124 1.00 NOD1 (0.60) NOD1S1PR1S1PR3PLA2G2CGPR84
SCHEMBL1220169 1.00 NOD1 (0.60) NOD1S1PR1S1PR3PLA2G2CGPR84
SCHEMBL7780467 1.00 NOD1 (0.60) NOD1S1PR1S1PR3PLA2G2CGPR84
SCHEMBL7351269 1.00 NOD1 (0.60) NOD1S1PR1S1PR3PLA2G2CGPR84
SCHEMBL7781962 1.00 NOD1 (0.60) NOD1S1PR1S1PR3PLA2G2CGPR84
SCHEMBL9005575 1.00 NOD1 (0.60) NOD1S1PR1S1PR3PLA2G2CGPR84
SCHEMBL30480112 1.00 NOD1 (0.60) NOD1S1PR1S1PR3PLA2G2CGPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190263880-A1 PROCESS FOR PREPARATION OF PROTEIN OR PEPTIDE DR REDDY?S LABORATORIES LTD (IN) 2019-08-29 US disclosed
CN-106726670-A A kind of skin protection cosmetics comprising N acyl aminos hydrochlorate/plant peptide combinations and preparation method thereof 长沙普济生物科技股份有限公司 2017-05-31 CN disclosed
CN-100535030-C Polyamino acids functionalized by alpha-tocopherol and use thereof, in particular pharmaceutical use FLAMEL TECH SA (FR) 2009-09-02 CN disclosed
CN-101386677-A Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications FLAMEL TECH SA (FR) 2009-03-18 CN disclosed
CN-1659214-A Polyamino acids functionalized by alpha-tocopherol and use thereof, in particular pharmaceutical use FLAMEL TECH SA (FR) 2005-08-24 CN disclosed
EP-1135398-A1 CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION Monsanto Technology LLC (US) 2001-09-26 EP disclosed
US-6218563-B1 Cyanophosphonamides and method for preparation MONSANTO COMPANY 2001-04-17 US disclosed
WO-2000032611-A1 CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION MONSANTO TECHNOLOGY LLC (US) 2000-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190263880-A1 PROCESS FOR PREPARATION OF PROTEIN OR PEPTIDE RPS27A, MRPL21, PSMB11 NOD1 2494/4885S1PR1 4577/4885S1PR3 4606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.